Cosmos Innovation, a solar AI tech solutions firm, has raised $19.7 million in Series A funding led by Xora Innovation, an early-stage, deep-tech investment platform of Temasek,

Cosmos Innovation, a solar AI tech solutions firm, has raised $19.7 million in Series A funding led by Xora Innovation, an early-stage, deep-tech investment platform of Temasek,
raicoon, a provider of AI-based solutions for autonomous solar operations, raised €4 million (~$4.2 million) in a seed funding round. Premier climate, tech, and impact
UgoWork, a Canada-based provider of lithium-ion batteries and energy monitoring solutions, announced the closing of its all-equity C$22.8 million (~$17.08 million) Series B funding round
Fluence, a provider of energy storage products and services and digital applications for renewables and storage, has agreed to acquire Nispera, a Zurich-based company providing
Olive, an AI-powered healthcare process automation company, empowering organizations to improve efficiency and patient care, raises $400 million. Vista Equity Partners led the round, with
Syllable, an AI-powered patient engagement platform, raised $28 million in a Series B funding round. Oak HC/FT led the round with participation from previous investor
XSOLIS, a healthcare technology firm using artificial intelligence to solve operational and financial challenges in healthcare, secured a $75 million minority growth investment from Brighton
xCures, an AI-powered precision oncology platform, raised $12.69 million in Series A funding, led by Boehringer Ingelheim Venture Fund. Vanedge Capital, Harmonix Fund, and Metaplanet
Alayacare, an AI-powered cloud-based home health care software company, raised C$225 million (~$183 million) in a Series D round led by Generation Investment Management with
Cleerly, an AI-powered medical imaging company creating a new standard of care for coronary artery disease, raised $43 million in Series B funding. Vensana Capital